Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CONTESSA 2: A multinational, multicenter, phase 2 study of tesetaxel plus a reduced dose of capecitabine in patients with HER2-, HR+ metastatic breast cancer (MBC) who have not previously received a taxane
    Meeting Abstract

    Schwartzberg, L.; Asselah, J.; Bondarenko, I.; Chae, Y.; DaCosta, N.; Feng, Y. H.; Izarzugaza, Y.; Lemieux, J.; Liu, M. C.; Marx, G.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Chemotherapy-related amenorrhea (CRA) after adjuvant trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT trial)
    Meeting Abstract

    Ruddy, K. J.; Trippa, L.; Hu, J.; Barry, W. T.; Dang, C. T.; Yardley, D. A.; Isakoff, S. J.; Valero, V. V.; Faggen, M. G.; Mulvey, T. M.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Treatment patterns for metastatic hormone receptor-positive breast cancer: Comparing expert and community practice
    Meeting Abstract

    Quill, T.; Hurvitz, S.; Miller, K. D.; O'Regan, R.; Traina, T. A.; Andrie, R.; Obholz, K. L.; Jahanzeb, M.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • OlympiAD extended follow-up for overall survival and safety: Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer
    Meeting Abstract

    Robson, M.; Im, S. A.; Senkus, E.; Xu, B.; Domchek, S.; Masuda, N.; Delaloge, S.; Li, W.; Tung, N.; Armstrong, A.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • The genomic landscape of endocrine-resistant metastatic breast cancer
    Meeting Abstract

    Razavi, P.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • CONTESSA: A multinational, multicenter, randomized, phase 3 registration study of tesetaxel plus a reduced dose of capecitabine in patients with HER2-, hormone receptor + (HR+) metastatic breast cancer (MBC) who have previously received a taxane
    Meeting Abstract

    O'Shaughnessy, J.; Piccart, M.; Schwartzberg, L.; Cortes, J.; Harbeck, N.; Im, S. A.; Rugo, H.; Untch, M.; Yardley, D.; Bondarenko, I.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Methylation profiling of mucinous breast cancer
    Meeting Abstract

    Pareja, F.; Ferrando, L.; da Silva, E. M.; Da Cruz Paula, A.; Stylianou, A.; Brown, D. N.; Selenica, P.; Serrano, J.; Wen, H. Y.; Zhang, H.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Patient reported outcomes from the adjuvant trastuzumab emtansine (T-DM1) vs. paclitaxel + trastuzumab (TH) (ATEMPT) trial (TBCRC 033)
    Meeting Abstract

    Partridge, A.; Zheng, Y.; Rosenberg, S.; Gelber, R.; Gelber, S.; Barry, W.; Dang, C.; Yardley, D.; Isakoff, S.; Valero, V.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • The genomic landscape of metastatic special histologic types of breast cancer
    Meeting Abstract

    Pareja, F.; Lee, S. S. K.; Beca, F.; Ferrando, L.; Selenica, P.; Brown, D. N.; Wen, H. Y.; Zhang, H.; Brogi, E.; Razavi, P.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • A randomized phase 2 study of peri-operative ipilimumab, nivolumab and cryoablation versus standard care in women with residual, early stage/resectable, triple negative breast cancer after standard-of-care neoadjuvant chemotherapy
    Meeting Abstract

    McArthur, H.; Comen, E.; Bryce, Y.; Solomon, S. B.; Leal, J.; Rodine, M.; Abaya, C. D.; Patil, S.; Page, D.; Norton, L.
    Cancer Research (2020)

    Fulltext@MSK | Save